Pharmacovigilance Outsourcing Market 2019 | Dynamics, Forecast, Analysis and Supply Demand 2025

U.S. pharmacovigilance outsourcing market size dominated North America region and was valued at USD 783.2 million revenue in 2017 and is estimated to witness similar trend during the forthcoming years. The high growth is attributed to strong foothold of major pharma and medical device companies coupled with extensive drug development activities in the U.S. Moreover, high healthcare expenditure in the country and growing concern regarding drug safety and adverse drug reactions among the population will boost pharmacovigilance outsourcing business growth.

China pharmacovigilance outsourcing market held significant revenue share in 2017 and is projected to show highest CAGR of 16.7% over the forecast timeframe. The growth is attributable to the comprehensive pharmacovigilance system in China that covers organizations and regulations related to pharmacovigilance outsourcing. Furthermore, availability of Adverse Drug Reaction (ADR) Monitoring System, a spontaneous reporting system in China that connects the four-level pharmacovigilance network will render positive impact on the market growth.Increasing emphasis of several pharma and biopharma companies on new drug development for treatment of chronic diseases is one of the key drivers that will render positive impact on the pharmacovigilance (PV) outsourcing market growth. Pharmaceutical companies need to focus on several pharmacovigilance activities including remote monitoring for clinical trials, clinical operations, regulatory affairs, statistical analysis, quality assurance, evaluation and approvals of the project with necessary clearances and documentation. Setting up in-house PV department is not always cost effective and involves several challenges such as high costs for maintaining compliance levels and availability of trained in-house human resource. Growing inclination of pharma companies towards PV outsourcing facilities offering aforementioned functions will boost pharmacovigilance outsourcing industry growth in the coming years.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3030

Germany pharmacovigilance outsourcing market was valued at USD 185.4 million in 2017, as a result of the presence of well-established players providing pharmacovigilance activities to major pharmaceutical companies. Germany based BPOs are well-known for knowledge processing IT services and with enormous client-base these companies acquire majority of the market share. Aforementioned factor along with growing cases of ADRs will favor the industry growth.

India pharmacovigilance outsourcing market accounted for 19.5% revenue share and is anticipated to have exponential growth during the forecast timeframe. Presence of large number of companies providing drug safety outsourcing services will trigger the industry growth in India. Also, favorable government initiatives coupled with developing regulatory landscape will escalate the industry growth in near future.

Furthermore, pharmaceutical drugs used in prevention and treatment of diseases have a high risk of adverse drug reactions (ADRs) that can cause serious harm to patients. This has led to increased focus of companies on monitoring of adverse drug reactions throughout the product life cycle, from pre-clinical trials to post-market surveillance. Thus, growing need for detection, assessment, understanding and prevention of ADRs will surge the demand for pharmacovigilance activities thereby accelerating the market growth. However, issues pertaining to data security and dearth of skilled professionals for performing PV functions may impede pharmacovigilance outsourcing business growth during the forecast period.

Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Pharmacovigilance outsourcing industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Service trends
2.1.3. Service provider trends
2.1.4. Regional trends
Chapter 3. Pharmacovigilance Outsourcing Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Cost effective pharmacovigilance services in developing regions
3.3.1.2. High profile drug recalls due to safety concerns
3.3.1.3. Benefits offered by outsourced compliance providers over in-house compliance functions
3.3.1.4. Increasing adverse drug reactions and drug toxicity
3.3.2. Industry pitfalls and challenges
3.3.2.1. Risk associated with data security
3.3.2.2. Dearth of skilled personnel
3.4. Growth potential analysis
3.4.1. By service
3.4.2. By service provider
3.5. Regulatory landscape
3.6. Porter's analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis

Browse Report Summary @ https://www.gminsights.com/industry-analysis/pharmacovigilance-outsourcing-market

Post-marketing services segment dominated the pharmacovigilance outsourcing market with USD 2.1 billion revenue in 2017 and is estimated to show significant growth over the analysis timeline. Segmental growth is attributable to the increasing number of ADRs associated with the newly developed drugs. Growing demand for several post-marketing services including adverse event case analysis and reporting, regulatory submission, reconciliation of pharmacovigilance database with clinical database and population studies & pharmaco-epidemiology assessment will spur the segment size.

Contract research organizations (CROs) segment accounted for the largest revenue share in 2017 and is estimated to witness 15.9% CAGR during the forecast timeframe. The segment growth is attributed to various case management activities that are majorly outsourced to the CROs. Increasing focus of the top CROs including IQVIA, Parexel and SIRO Clinpharm on developing innovative PV services such as medical writing, safety surveillance services and case processing services will further accelerate the segment growth in coming years.

More insightful info @ https://www.marketwatch.com/press-release/pharmacovigilance-outsourcing-market-size-2019-outlook-opportunity-and-demand-analysis-report-by-2025-2020-01-20

Prominent industry players operating in the pharmacovigilance outsourcing market are Accenture, Bioclinica, , Clintec, Cognizant, Covance, Ergomed, Genpact, IBM Corporation, ICON, iGATE Corporation, iMED Global Corporation, Infosys, IQVIA, MarksMan Healthcare, Medpace Holdings, Novartis, Oracle Corporation, Parexel, PRA Health Sciences, SIRO Clinpharm, Symogen, Syneos Health, Tata Consultancy Services (TCS) and Tech Mahindra. Key industry players are majorly focusing on strategic initiatives including acquisitions, merger and partnerships to strengthen market position and capitalize on market opportunities. For instance, in June 2018, Genpact acquired Commonwealth Informatics, a leading provider of cloud-based drug safety analytics services and products for medical research and healthcare delivery. The strategy will help Genpact to strengthen its pharmacovigilance AI capabilities for ensuring drug safety thereby fostering company's growth.

Related Reports:
Mice Model Market: https://pharmaphorum.com/partner-content/mice-model-market-will-achieve-7-7-cagr-up-to-2025/

Pharmacovigilance Market: https://pharmaphorum.com/partner-content/pharmacovigilance-market-size-will-achieve-10-6-cagr-up-to-2025/

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.